Matrix Metalloproteinase-9/Tissue Inhibitor of Matrix Metalloproteinase-1 Ratio is Associated with the Severity and Major Adverse Cardiovascular Event in Patients with Systolic Heart Failure

被引：0

作者：

Morishita, Tetsuji ^{[1
]}

Mitsuke, Yasuhiko ^{[1
]}

Nakano, Akira ^{[1
]}

Uzui, Hiroyasu ^{[1
]}

Geshi, Toru ^{[1
]}

Amaya, Naoki ^{[1
]}

Sarazawa, Katsuhiko ^{[1
]}

Sato, Takehiko ^{[1
]}

Ishida, Kentaro ^{[1
]}

Fukuoka, Yoshitomo ^{[1
]}

Ikeda, Hiroyuki ^{[1
]}

Murakami, Kiwamu ^{[1
]}

Lee, Jong-Dae ^{[1
]}

机构：

[1] Univ Fukui Hosp, Fukui, Japan

来源：

CIRCULATION | 2011年 / 124卷 / 21期

关键词：

Heart failure; Biomarkers;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A12428

引用

页数：2

共 50 条

[1] MATRIX METALLOPROTEINASE-9 IS ASOCIATED WITH THE SEVERITY AND MAJOR ADVERSE CARDIOVASCULAR EVENT IN PATIENTS WITH SYSTOLIC HEART FAILURE
Morishita, Tetsuji
Uzui, Hiroyasu
Arakawa, Kenichiro
Amaya, Naoki
Kaseno, Kenichi
Ishida, Kentaro
Sato, Takehiko
Fukuoka, Yoshitomo
Ikeda, Hiroyuki
Ikeda, Etsuko
Fujii, Ako
Koike, Machiko
Sato, Yusuke
Hisazaki, Kaori
Yamaguchi, Junya
Lee, Jong-Dae
Tada, Hiroshi
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A796 - A796
[2] Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in congestive heart failure
Gerlach, Raquel F.
Tanus-Santos, Jose E.
[J]. AMERICAN HEART JOURNAL, 2006, 152 (01)
[3] Disparity between matrix metalloproteinase-9 and tissue inhibitors of matrix metalloproteinase-1 correlated with the severity and adverse prognosis in patients with heart failure and systolic dysfunction
Morishita, T.
Mitsuke, Y.
Nakano, A.
Uzui, H.
Geshi, T.
Amaya, N.
Sarazawa, K.
Sato, T.
Ishida, K.
Lee, J. D.
[J]. EUROPEAN HEART JOURNAL, 2011, 32 : 288 - 288
[4] Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in congestive heart failure - Reply
Fonarow, Gregg C.
Horwich, Tamara B.
Eshaghian, Shervin
[J]. AMERICAN HEART JOURNAL, 2006, 152 (01)
[5] Modulation of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in sepsis
Maitra, Subir R.
Jacob, Asha
Zhou, Mian
Wang, Ping
[J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2010, 3 (03): : 180 - 185
[6] Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in multiple sclerosis
Boz, Cavit
[J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2006, 108 (06) : 618 - 618
[7] Sputum matrix metalloproteinase-9: Tissue inhibitor of metalloproteinase-1 ratio in acute asthma
Tanaka, H
Miyazaki, N
Oashi, K
Tanaka, S
Ohmichi, M
Abe, S
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (05) : 900 - 905
[8] Children with stable asthma have reduced airway matrix metalloproteinase-9 and matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio
Doherty, GM
Kamath, SV
de Courcey, F
Christie, SN
Chisakuta, A
Lyons, JD
Heaney, LG
Ennis, M
Shields, MD
[J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2005, 35 (09): : 1168 - 1174
[9] Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 in Sepsis after Major Abdominal Surgery
Bojic, Suzana
Kotur-Stevuljevic, Jelena
Aleksic, Aleksandra
Gacic, Jasna
Memon, Lidija
Simic-Ogrizovic, Sanja
[J]. DISEASE MARKERS, 2018, 2018
[10] Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in perinatal asphyxia
Sunagawa, Shinpei
Ichiyama, Takashi
Honda, Rie
Fukunaga, Shinnosuke
Maeba, Shinji
Furukawa, Susumu
[J]. BRAIN & DEVELOPMENT, 2009, 31 (08): : 588 - 593

← 1 2 3 4 5 →